Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Burcon NutraScience Corp (BRCNF) had Revenue of $0.25M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$0.25M
Net Income	$-2.51M
Cost of Goods Sold	$1.28M
Gross Profit	$-1.04M
Operating Expenses	$2.04M
Operating Income	$-1.79M
Non-Operating Income/Expense	$-0.72M
Pre-Tax Income	$-2.51M
Normalized Pre-Tax Income	$-2.51M
Income after Taxes	$-2.51M
Income from Continuous Operations	$-2.51M
Consolidated Net Income/Loss	$-2.51M
Normalized Income after Taxes	$-2.51M
EBIT	$-1.79M
EBITDA	$-1.42M
Weighted-Average Shares Outstanding (Basic)	12.69M
Weighted-Average Shares Outstanding (Diluted)	12.69M
Earnings per Share (EPS) (Basic)	$-0.20
Earnings per Share (EPS) (Diluted)	$-0.20
Balance Sheet Financials
Current Assets	$3.90M
Property, Plant, and Equipment	$0.79M
Long-Term Assets	$15.59M
Total Assets	$19.49M
Current Liabilities	$3.18M
Long-Term Debt	$13.71M
Long-Term Liabilities	$13.71M
Total Liabilities	$16.89M
Common Equity	$2.60M
Tangible Shareholders Equity	$1.69M
Shareholders Equity	$2.60M
Common Shares Outstanding	12.69M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.94M
Cash Flow from Investing Activities	$-0.08M
Cash Flow from Financial Activities	$-0.06M
Beginning Cash	$5.26M
End Cash	$3.06M
Increase/Decrease in Cash	$-2.20M
Stock-Based Compensation	$0.09M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.23
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.84
Debt to Equity Ratio	6.19
Gross Margin	-419.21%
Operating Margin	-723.40%
EBIT Margin	-723.40%
EBITDA Margin	--
Pre-Tax Profit Margin	-1015.54%
Profit Margin	-1015.54%
Free Cash Flow	$-2.04M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	4.74
Receiveable Turnover	0.63
Days Sales in Receivables	142.08
Return on Equity	-96.60%
Return on Tangible Equity	-148.36%
Return on Assets	-12.89%
Return on Investments	-15.41%
Book Value Per Share	$0.20
Free Cash Flow per Share	$-0.16
Operating Cash Flow per Share	$-0.15

Data from Zacks Investment Research, Inc.